ATEL Capital Group

ATEL Capital Group, founded in 1977 and headquartered in San Francisco, California, is a financial services firm focused on providing a variety of funding solutions to support the growth of emerging companies. The firm specializes in senior secured financing, offering loans for business-necessary equipment and growth capital across multiple industries, including information technology, life sciences, and green technologies. ATEL Capital Group collaborates with leading investment firms to deliver flexible financing options that cater to the diverse needs of pre-IPO and growth-stage companies. By combining expertise in equipment leasing, asset-based lending, and venture financing, the company is positioned to respond effectively to the evolving demands of its clients and to foster innovation across various sectors.

Steven Rea

President and Managing Director

James E. Ryan

VP

28 past transactions

Isar Aerospace

Debt Financing in 2024
Isar Aerospace is a space technology company specializing in the development of automated production methods for rockets. The company focuses on providing launch services that facilitate the deployment and resupply of satellite constellations, aimed at offering low-cost and flexible access to space for small satellites. By prioritizing affordability and sustainability, Isar Aerospace enables clients to utilize environmentally friendly solutions for launching small payloads and upper-stage vehicles.

Pendulum Therapeutics

Venture Round in 2023
Pendulum Therapeutics Inc. is a microbiome-focused company based in San Francisco that specializes in developing medical probiotics and prebiotics aimed at managing chronic illnesses, particularly type 2 diabetes. The company's flagship product, Pendulum Glucose Control, was introduced in 2020 and has demonstrated effectiveness in lowering blood sugar spikes and reducing A1C levels, as evidenced by published clinical trials. Pendulum utilizes evidence-based microbiome science and DNA sequencing to create targeted interventions, allowing clinicians to identify specific microbiome markers for disease treatment. Founded in 2013, Pendulum holds 13 patents and has 42 pending, with significant backing from prominent investors. The company sells its products online, focusing on improving healthcare through innovative microbiome therapies.

ARRIS

Venture Round in 2023
ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

Astranis

Debt Financing in 2023
Astranis is a satellite technology developer focused on providing high-speed internet access to underserved regions. The company aims to address the digital divide by launching satellites that can transmit data to specific terrestrial locations, facilitating internet connectivity for the estimated 4 billion people worldwide who currently lack access. By offering reliable internet services at significantly lower costs than traditional methods, Astranis enables governments and businesses to connect communities and expand internet access globally.

Plant Prefab

Debt Financing in 2022
Plant Prefab specializes in custom construction services for single and multi-family homes, utilizing a patented prefabricated building system designed to enhance efficiency and sustainability. By employing advanced digital modeling and customizable Plant Panels and Modules, the company enables contractors and developers to accelerate the building process by 20 to 50 percent compared to traditional methods. This innovative system not only improves quality control but also offers greater design flexibility while reducing costs and material waste. Committed to sustainable practices, Plant Prefab has achieved carbon-neutral operations since 2020 and is recognized as the first housing prefabricator to pursue a net zero goal. The company aims to create healthier homes while minimizing the environmental impact of construction.

Hexagon Bio

Venture Round in 2022
Hexagon Bio, Inc. is a biotechnology company based in Menlo Park, California, focused on discovering novel drugs for diseases that lack effective treatments. Established in 2016, the company utilizes a data-driven approach that combines genomics, synthetic biology, and computational techniques. By mining genomic data from fungal genomes, Hexagon Bio aims to identify targeted small molecule therapeutics. Its proprietary platform leverages data science to engineer drugs from DNA sequences, enabling the identification of small molecule inhibitors that interact with specific target proteins. This innovative method allows researchers to tap into the global metagenome, facilitating the development of new medicines aimed at improving patient outcomes.

Activ Surgical

Series B in 2022
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Function of Beauty

Venture Round in 2022
Function of Beauty is a New York-based beauty brand founded in 2015 by Hien Nguyen, Joshua Maciejewski, and Zahir Dossa. The company specializes in personalized hair care, skin care, and body care products, allowing customers to create customized shampoos, conditioners, and styling products tailored to their individual hair profiles and specific goals. Function of Beauty emphasizes the use of high-quality ingredients, ensuring that its products are free from sulfates, parabens, phthalates, and mineral oils, which may be harmful to consumers. By focusing on personalization and safety, the brand aims to meet the unique beauty needs of each customer.

Apeel Sciences

Debt Financing in 2022
Apeel Sciences produces products including avocados, apples, mangos, cucumbers, and citrus protected by plants. They support the plant’s natural ability to protect against environmental stress by maintaining moisture and reducing oxidation.

Lightship

Series C in 2021
Lightship is a company founded in 2018 that focuses on enhancing access, choice, and equity in clinical trials through decentralized and hybrid clinical services. By leveraging innovations in digital health and technology, Lightship aims to transform the clinical research landscape by improving patient experiences, retention, and trial diversity. The company moves beyond traditional research centers to make clinical studies more accessible, allowing medical research organizations to overcome the barriers and inefficiencies associated with conventional clinical trial models. Its mission centers on placing patients at the forefront, ensuring that clinical research is designed to meet the needs of diverse populations globally.

Plant Prefab

Debt Financing in 2021
Plant Prefab specializes in custom construction services for single and multi-family homes, utilizing a patented prefabricated building system designed to enhance efficiency and sustainability. By employing advanced digital modeling and customizable Plant Panels and Modules, the company enables contractors and developers to accelerate the building process by 20 to 50 percent compared to traditional methods. This innovative system not only improves quality control but also offers greater design flexibility while reducing costs and material waste. Committed to sustainable practices, Plant Prefab has achieved carbon-neutral operations since 2020 and is recognized as the first housing prefabricator to pursue a net zero goal. The company aims to create healthier homes while minimizing the environmental impact of construction.

Iron Ox

Series A in 2019
Iron Ox, Inc. is a company that specializes in developing robotic systems for sustainable agriculture. Founded in 2015 and headquartered in San Carlos, California, Iron Ox operates greenhouses in Gilroy, California, and Lockhart, Texas. The company utilizes advanced plant science, machine learning, and robotics to cultivate fresh, pesticide-free produce, including a variety of leafy greens and culinary herbs. One of its key innovations is Angus, an autonomous mobile robot designed for crop harvesting. By integrating technology into farming practices, Iron Ox aims to reduce the environmental impact of agriculture while enhancing the quality and availability of fresh produce for consumers.

Emulate

Series B in 2016
Emulate, Inc. specializes in organ-on-chip technology that simulates human biology to enhance the understanding of how diseases, medications, chemicals, and food impact human health. The company develops organ-chips for various organs, including the lung, intestine, liver, and skin, which replicate normal functions and disease conditions. Emulate's innovative technology offers researchers a more accurate alternative to traditional experimental methods, such as cell cultures and animal testing, by providing detailed insights into human biological responses. Additionally, the company supplies drug development and instrumentation software to facilitate research and development workflows for its clients. Emulate serves a diverse range of sectors, including biotechnology, pharmaceuticals, consumer health, cosmetics, chemicals, food, agrochemicals, government agencies, and academic institutions. Founded in 2013 and headquartered in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. until its name change in 2014.

Emulate

Series B in 2016
Emulate, Inc. specializes in organ-on-chip technology that simulates human biology to enhance the understanding of how diseases, medications, chemicals, and food impact human health. The company develops organ-chips for various organs, including the lung, intestine, liver, and skin, which replicate normal functions and disease conditions. Emulate's innovative technology offers researchers a more accurate alternative to traditional experimental methods, such as cell cultures and animal testing, by providing detailed insights into human biological responses. Additionally, the company supplies drug development and instrumentation software to facilitate research and development workflows for its clients. Emulate serves a diverse range of sectors, including biotechnology, pharmaceuticals, consumer health, cosmetics, chemicals, food, agrochemicals, government agencies, and academic institutions. Founded in 2013 and headquartered in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. until its name change in 2014.

Ionic Materials

Venture Round in 2015
Ionic Materials, Inc. is a Woburn, Massachusetts-based company founded in 1986 that specializes in the development of solid polymer electrolyte materials for batteries. The company’s innovative polymer electrolyte technology represents a significant advancement in battery design, offering improved safety, cost-efficiency, and performance without the traditional trade-offs. This breakthrough enables the creation of batteries that meet the growing demands of various industries while addressing the challenges faced by original equipment manufacturers and other producers who need to innovate but may lack the resources for material development. Ionic Materials aims to collaborate with key partners in the battery sector to bring its advanced technology to market.

Edeniq

Venture Round in 2012
Edeniq Inc. is a biotechnology company specializing in the conversion of cellulosic biomass into industrial sugars and cellulosic ethanol. Founded in 2006 and headquartered in Visalia, California, the company has developed innovative technologies, including the Cellunator, a device that enhances starch extraction from corn, and the Intellulose platform, which allows for the production of cellulosic ethanol from corn kernel fiber. Edeniq's solutions are designed for easy integration into existing ethanol production facilities without requiring significant capital investment. The company licenses its technologies to bio-refineries in the United States and Brazil, helping them improve efficiency and increase the yield of valuable biofuels and biochemicals.

iPierian

Series B in 2010
iPierian is a biotechnology company specializing in the development of therapies for neurodegenerative diseases. Utilizing induced pluripotent stem cells, the company focuses on addressing significant unmet medical needs, particularly in conditions such as spinal muscular atrophy, amyotrophic lateral sclerosis, and Parkinson's disease. iPierian is engaged in the research and development of innovative therapies, including monoclonal antibodies aimed at treating Alzheimer's disease and other Tauopathies. By targeting the mechanisms that drive disease progression, the company aims to provide physicians with effective tools to slow the spread of Tau in the brain, thereby potentially improving patient outcomes.

SolFocus

Venture Round in 2010
SolFocus's mission is to enable solar energy generation at a Levelized Cost of Energy (LCOE) competitive with traditional fossil fuel sources. To achieve this goal, SolFocus has developed leading concentrator photovoltaic (CPV) technology which combines high-efficiency solar cells (approaching 40%) and advanced optics to provide solar energy solutions which are scalable, dependable and capable of delivering on the promise of clean, low-cost, renewable energy.

NexPlanar

Debt Financing in 2010
NexPlanar Corporation specializes in the manufacturing of chemical mechanical planarization (CMP) pads for the semiconductor device industry. Founded in 2003 and headquartered in Hillsboro, Oregon, the company also operates a manufacturing facility in Hopkins, Minnesota. NexPlanar's products include hard, mid-hard, and ultra-soft pads that utilize proprietary nano-domain technology, patented molded grooves, and a unique tuning capability. These innovations lead to significantly improved yields and lower costs of ownership, while extending the life of the pads. The company serves semiconductor fabrication operations globally and was previously known as Neopad Technologies Corporation before rebranding in 2008. As of October 2015, NexPlanar operates as a subsidiary of Cabot Microelectronics Corporation.

IntelePeer

Venture Round in 2009
IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

OpSource

Venture Round in 2009
Dimension Data, formerly known as OpSource, is a provider of cloud and managed hosting solutions designed to help businesses of all sizes accelerate growth and scale operations effectively. Established in 2002, the company offers a comprehensive Application Operations service that surpasses traditional hosting by delivering application management, change management, performance management, and application optimization. This approach allows clients to benefit from the flexibility, availability, and community of public cloud services while ensuring the security, performance, and control required by enterprise environments. Dimension Data is certified with SAS 70 Type II, PCI DSS Level 1, and adheres to European Safe Harbor standards, with operations in California, Virginia, the UK, Ireland, and India. The company supports over four hundred Software-as-a-Service independent software vendors, cloud platform providers, carriers, and enterprises, enabling them to manage high-availability, business-critical hosting environments efficiently.

Enerkem

Venture Round in 2009
Enerkem Inc. is a cleantech company based in Montreal, Canada, specializing in the production of renewable biofuels and chemicals derived from waste materials. The company utilizes a proprietary thermochemical process to convert non-recyclable municipal solid waste into cellulosic ethanol and other renewable chemicals. Over a decade of research has validated Enerkem's technology, which addresses issues related to oil dependence and waste disposal. The company operates advanced facilities that support its business model of producing biofuels profitably from a diverse range of feedstocks. Enerkem is majority-owned by a mix of institutional and clean-technology investors, including various venture capital firms and industrial investors. With a workforce of approximately 170 employees across Canada and the United States, Enerkem is committed to transforming waste into sustainable energy solutions.

GangaGen

Seed Round in 2008
GangaGen, Inc. is a clinical-stage biotechnology company based in Palo Alto, California, with research and development operations in Bangalore, India. Founded in 2000, the company specializes in discovering and developing novel therapeutic proteins aimed at treating infectious diseases, particularly those caused by antibiotic-resistant bacteria. Its lead product, StaphTAME, is a recombinant protein designed for the topical prevention and treatment of staphylococcal infections, including methicillin-resistant Staphylococcus aureus (MRSA). GangaGen employs a proprietary platform to create highly specific therapeutic proteins known as ectolysins, which target clinically significant bacterial strains, offering innovative solutions for serious infections such as pneumonia and neonatal sepsis caused by multidrug-resistant organisms.

Innovalight

Venture Round in 2008
Innovalight, founded by Conrad Burke, specializes in the development of high-efficiency, low-cost solar modules utilizing innovative silicon-based technology. The company has created a unique silicon ink, which has been in development since 2005, enabling a shift in manufacturing processes by employing liquid-based processing instead of traditional solid or gas methods. This approach aims to significantly enhance the cost-effectiveness and efficiency of solar modules. Innovalight's products are designed for both residential and commercial applications, focusing on ultra thin-film power modules to support grid-connected solar power generation.

Axial Biotech

Debt Financing in 2008
Axial Biotech is a privately held, venture-backed company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. Axial Biotech is focused on developing and commercializing genetic tests and treatment solutions for spinal disorders.

Buyerlink

Series C in 2007
BuyerLink LLC is an online marketing platform that specializes in acquiring locally-targeted and category-specific consumers on a cost-per-click or cost-per-lead basis. Founded in 2001 and based in Walnut Creek, California, BuyerLink offers a range of solutions for businesses of all sizes, simplifying the online marketing process by removing the need for complex and costly infrastructures. The platform serves various industries, including automotive, real estate, home improvement, mortgage, travel, and insurance, providing efficient marketing solutions that connect advertisers with potential customers. Formerly known as Reply.com, the company rebranded to BuyerLink LLC in October 2015 and operates as a subsidiary of One Planet Ops Inc.

Cornice

Funding Round in 2006
Cornice, Inc. provides storage elements for consumer electronics devices. Its storage element is built into various consumer products, including mobile phones, MP3 players, personal video recorders, GPS devices, and portable storage products. The company offers Crash Guard, which consists of active latch, skip control, and drop safe. It serves consumer electronics manufacturers. The company was founded in 2000 and is headquartered in Longmont, Colorado with integration centers in Hong Kong, Japan, and Taiwan.

Aryx Therapeutics

Series D in 2004
Aryx Therapeutics is a biopharmaceutical company dedicated to developing innovative drug candidates that address safety concerns associated with established oral therapies for chronic diseases. Leveraging its expertise in retrometabolic drug design, Aryx aims to create safer alternatives to commercially successful medications. The company is committed to improving patient outcomes through its internally developed products, which are designed to mitigate known safety issues and enhance the effectiveness of existing treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.